EXPOSED
Almost nothing a phlebotomist does is text or screen work: you find a vein on a dehydrated 88-year-old, calm a needle-phobic teenager, and get a clean draw in one stick. Language AI cannot touch that, and automated venipuncture devices remain lab curiosities rather than deployed hardware. The real exposure is regulatory and structural — only four states license phlebotomy, certification is employer-driven, and the specimen-labeling, order-entry, and scheduling half of the shift is already being absorbed by lab information systems and self-service check-in.
Headcount grew steadily across the period.
Median pay $35,510 → $45,230 +1.9% in real terms
This line is counted by the Bureau of Labor Statistics — the one figure on this page that isn't a judgement of ours. Headcount moves on demand, offshoring, demographics and the business cycle, and automation is one term among several, often not the loudest.
So a falling line is not evidence that AI did it, and a rising one is not evidence that it won't. Both happen in this register: some occupations resist automation and shrink anyway, others are highly automatable and keep growing. The marked year is 2020.
BLS projection, 2024–2034
+5.6% 139,700 → 147,500 on the projections basis
Growing, and only partly exposed
The BLS expects +5.6% more of these jobs by 2034, and at 62/100 the work is only partly exposed — some tasks are automatable, the core of the job is not. Nothing here is in tension.
Different clocks. The score is what current AI could do to this work today. The projection is how many of these jobs will exist in 2034. Everything between the two — how fast employers actually adopt, whether demand grows in the meantime — is why they can point opposite ways without either being wrong.
~18,400 openings a year on average, including replacing people who leave.
PhlebotomistVenipuncturistMobile ExaminerMobile PhlebotomistTravel PhlebotomistClinical PhlebotomistCollection TechnicianPhlebotomy TechnicianResearch PhlebotomistCertified PhlebotomistLab Liaison TechnicianLaboratory PhlebotomistOutpatient PhlebotomistPhlebotomy TechnologistRegistered PhlebotomistLong Term Care PhlebotomistPhlebotomy Services TechnicianCertified Phlebotomy TechnicianPatient Service Technician (PST)Phlebotomy Services Representative
Holding it up: embodiment . Weakest point: liability shield .
Tasks largely resist digitisation Palpating for a vein that doesn't show, choosing between a butterfly and a 21-gauge on a chemo patient with scarred antecubitals, and re-sticking the back of the hand when the first attempt fails are motor-judgment tasks with no digital substitute — the 17 rather than 20 reflects that order entry, requisition matching, and courier logging genuinely are being taken over by LIS barcode workflows.
Hands-on in uncontrolled environments Every draw happens at a chair, a bedside, a nursing-home room, or in a bloodmobile with a patient who may faint, jerk, or vomit, and you handle sharps and biohazard tubes in that same uncontrolled space — the 18 sits just short of the top because your environment, while unpredictable, is at least indoors and largely known.
Certification preferred, not legally required Only California, Nevada, Louisiana, and Washington license phlebotomists at all; elsewhere your NHA, ASCP, or AMT certification is an employer hiring preference, and when a draw causes nerve injury or a mislabeled tube reaches the analyzer, the liability lands on the hospital, the lab director, and the ordering physician — the 7 credits real credentialing infrastructure that does not translate into personal legal standing.
Meaningful discretion Order of draw, tube additives, tourniquet time, and two-attempt limits are all protocol you follow rather than write; your discretion is real but bounded — deciding a patient is too dehydrated to stick, escalating to a nurse for a central line, or rejecting a hemolyzed specimen — which is why this is 8 and not in the teens.
The verdict above describes this occupation as a whole. Almost nobody does the typical version of a job — tick what's actually in your week and see how your own mix sits.
Your task mix speaks to task resistance (17/20 here) — how much of the day's work current AI already does. That is the dimension the boxes above are about.
It cannot move the other three. Liability shield (7/20) is whether the law requires a licensed human to sign. Trust premium (12/20) is whether buyers specifically pay for a person. Judgment and accountability (8/20) is whether the role exists to own consequential calls. Those are facts about the occupation's standing, not about which tasks are in your week — a paralegal who does only trial exhibits still holds no licence. Together they are 27 of this occupation's 62 points (44%).
Embodiment (18/20) is also a property of the work rather than the worker, but we don't tag individual tasks as physical or not, so the picker can't tell you anything about it. That's a limit of this tool, not a claim.
Did we get the list right? Tell us what's missing — the tasks are written from the outside, and you're reading this from the inside.
The moves above are yours to make. This is the other half: what would have to change in the world for the occupation itself to score higher. None of it is in any one person's gift, but it is where the floor actually comes from. Scores here are not a one-way ratchet. Only two of the five dimensions — task resistance and embodiment — track what machines can do. The other three track law, what buyers will pay for, and who is answerable, and those move in both directions, often in response to the same pressure AI creates. If every lever below landed, this occupation would score around 79/100 — SAFE.
Insurer or hospital-system credentialing rules requiring a certified phlebotomist (ASCP/NHA) as a condition of coverage for blood-collection-related malpractice, or a state rule that blood-bank type-and-crossmatch draws must be performed by a specifically certified collector — a real pattern already in transfusion-service policy after wrong-blood-in-tube events.
Growth of at-home and mobile draw services (Getlabs, Sprinter Health, decentralized clinical trials) where the household is explicitly paying a fee for a person to come and draw — plus trial sponsors requiring a named certified collector per FDA/ICH GCP source-data rules. That is a buyer paying for a specific human, not just a slot.
State-level phlebotomy licensure beyond the current four (CA, LA, NV, WA) — e.g. a bill creating a licensed phlebotomy technician title with board discipline and named accountability for specimen chain-of-custody and patient-identification errors. CLIA/CAP inspection findings increasingly cite pre-analytic errors, and lab accreditors (CAP checklist GEN.40450 competency requirements) tightening to require documented licensed-personnel sign-off on draw and label verification would push the same way.
Formal expansion of scope so the phlebotomist owns the call on specimen rejection, draw-order deviation, difficult-access escalation to IV team, and adverse-reaction response — codified in a competency standard rather than left to nursing. If routine scheduling and labeling are absorbed by LIS, the remaining shift is hard sticks, pediatric/geriatric access, and reject decisions, which is genuine task-mix shift into the judgment tier.
If automated venipuncture hardware stays in trials, the routine well-vein draw in high-volume patient service centers is the first thing any device would take, leaving pediatric, oncology, dialysis-access, and hard-stick work — a real two-tier structure. This rises only as a residue effect, not through any new capability.
The limit. Embodiment is already near maximum and cannot meaningfully rise. The binding constraint is volume, not defensibility: even fully licensed, headcount tracks draw volume, which falls if point-of-care testing, capillary microsampling, or wearable continuous monitoring reduce venipuncture demand. Licensure raises the score without protecting the number of jobs.
| New York-Newark-Jersey City, NY-NJ | 7,390 | $49,980 +11% |
| Chicago-Naperville-Elgin, IL-IN | 5,310 | $47,190 +4% |
| Los Angeles-Long Beach-Anaheim, CA | 4,720 | $52,940 +17% |
| Dallas-Fort Worth-Arlington, TX | 3,840 | $46,480 +3% |
| Miami-Fort Lauderdale-West Palm Beach, FL | 3,360 | $45,210 +0% |
| Phoenix-Mesa-Chandler, AZ | 2,940 | $46,260 +2% |
| Philadelphia-Camden-Wilmington, PA-NJ-DE-MD | 2,880 | $47,370 +5% |
| Atlanta-Sandy Springs-Roswell, GA | 2,790 | $49,370 +9% |
| Santa Rosa-Petaluma, CA | 100 | $62,350 +38% |
| San Jose-Sunnyvale-Santa Clara, CA | 350 | $60,600 +34% |
| Santa Maria-Santa Barbara, CA | 190 | $60,290 +33% |
Healthcare Asia Magazine reports Raffles Medical has implemented total laboratory automation in its clinical laboratory operations.
Has AI actually changed your work? One tap, anonymous, and the running tally is public. Nothing else is asked of you.
Rather than check back: get the digest and we'll tell you what changed — or watch a single occupation from its own page.